Literature DB >> 25844180

Crystal structure of N-{N-[N-acetyl-(S)-leuc-yl]-(S)-leuc-yl}norleucinal (ALLN), an inhibitor of proteasome.

Andrzej Czerwinski1, Channa Basava1, Miroslawa Dauter2, Zbigniew Dauter3.   

Abstract

The title compound, C20H37N3O4, also known by the acronym ALLN, is a tripeptidic inhibitor of the proteolytic activity of the proteasomes, enzyme complexes implicated in several neurodegenerative diseases and other disorders, including cancer. The crystal structure of ALLN, solved from synchrotron radiation diffraction data, revealed the mol-ecules in extended conformation of the backbone and engaging all peptide N and O atoms in inter-molecular hydrogen bonds forming an infinite anti-parallel β-sheet.

Entities:  

Keywords:  anti­parallel β-sheet.; crystal structure; hydrogen bonding; proteasome inhib­itor

Year:  2015        PMID: 25844180      PMCID: PMC4350719          DOI: 10.1107/S2056989015002091

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Chemical context

Proteasomes are high-mol­ecular-mass multicatalytic enzyme complexes localized in the nucleus and cytosol of all eukaryotic cells. As a part of the ubiquitin–proteasome pathway, the complex executes a remarkable set of functions, ranging from the complete destruction of abnormal and misfolded proteins to the specific proteolytic activation of crucial signaling mol­ecules (Adams, 2003 ▸; Groll & Potts, 2011 ▸). The ubiquitin–proteasome pathway has been implicated in several forms of malignancy, in the pathogenesis of some autoimmune disorders, the aging process related cardiac dysfunction, diabetic complications, and neurodegenerative diseases (e.g. Alzheimer’s, Parkinson’s, Huntington’s) (Dahlmann, 2007 ▸; Paul, 2008 ▸; Jankowska et al., 2013 ▸). Therefore, study of proteasome functions and the design and development of proteasome inhibitors is being pursued in many laboratories (Bennett & Kirk, 2008 ▸). A great amount of effort has been expended to explore proteasome inhibition as a novel targeted approach in cancer therapy. The first success came with FDA approval of Bortezomid for the treatment of multiple myeloma (Kane et al., 2006 ▸; Goldberg, 2012 ▸). Since then, numerous compounds have been reported to inhibit the components of the ubiquitin–proteasome system, and several new drug candidates undergoing clinical trials have emerged (Genin et al., 2010 ▸; Tsukamoto & Yokosawa, 2010 ▸; Frankland-Searby & Bhaumik, 2012 ▸; Jankowska et al., 2013 ▸). Peptide aldehydes were the first inhibitors designed to target the proteasome, and are still the most commonly used and best characterized group of such inhibitors (Kisselev et al., 2012 ▸). A notable one among them, Ac-Leu-Leu-Nle-H (ALLN, MG101), is also a potent inhibitor of nonproteasomal cysteine protease calpain I (Pietsch et al., 2010 ▸). ALLN, a cell-permeable tripeptide aldehyde reversible inhibitor of chymotripsin-like proteolytic activity of the proteasomes, was the first to be crystallized in a complex with an eukaryotic proteasome (Groll et al., 1997 ▸). Crystallographic analysis of the complex at 2.4 Å resolution revealed a structural organization of the proteasome and how the inhibitor binds to its active site. ALLN, as well as other peptide aldehydes, do it via reversible hemiacetal formation with the involvement of N-terminal threonine hy­droxy group in the proteasome β-subunits (Borissenko & Groll, 2007 ▸). The aldehyde structure derived from the crystal complex coordinates was used in mol­ecular modeling of inhibitor-proteasome inter­actions (Zhang et al., 2009 ▸). High resolution structural data from this study may provide better accuracy in future modeling of the inhibitor inter­actions with proteasome and other potential intra­cellular targets.

Structural commentary

We report here the crystal structure of ALLN refined against 0.65 Å resolution diffraction data measured with synchrotron radiation. The mol­ecule adopts an extended conformation of the backbone chain (Fig. 1 ▸) with the ϕ,ψ-torsion angles residing in the β region of the Ramachandran plot (Ramakrishnan & Ramachandran, 1965 ▸). All three consecutive peptide residues are in trans conformation and their ω angles are −179.42 (9), 173.77 (8), and 177.72 (10)°. The side chains of the two leucine and one norleucine residues have unstrained conformations, and do not deviate by more than 7° from either trans or gauche rotamers along the consecutive C—C bonds.
Figure 1

The mol­ecule of ALLN, showing the atom-labelling scheme. Displacement ellipsoids are drawn at the 50% probability level.

Supra­molecular features

All of the peptide ALLN N and O atoms are engaged in inter­molecular hydrogen bonds (Table 1 ▸) between mol­ecules related by the crystallographic 21 axis, forming an infinite anti­parallel β-sheet throughout the crystal (Fig. 2 ▸). The inter­actions between the sheets are mainly by the hydro­phobic contacts of the aliphatic amino acid side chains. The arrangement of ALLN molecules in the ac plane, interacting through their aliphatic side chains, is illustrated in Fig. 3 ▸.
Table 1

Hydrogen-bond geometry (, )

DHA DHHA D A DHA
N20H201O31i 0.882.052.897(3)161
N30H301O21ii 0.881.992.863(3)171
N40H401O12i 0.881.962.827(3)169

Symmetry codes: (i) ; (ii) .

Figure 2

Backbones of three neighboring mol­ecules of ALLN, forming a fragment of an anti­parallel β-sheet extending through the crystal. The amino acid side chains are not shown for clarity.

Figure 3

Arrangement of ALLN mol­ecules in the ac plane of the crystal, inter­acting through their aliphatic side chains.

Synthesis and crystallization

The title aldehyde was prepared according to the general synthetic procedure reported by Schaschke et al. (1996 ▸), and a 45% overall yield was obtained. The product was crystallized from aceto­nitrile.

Refinement details

Crystal data, data collection and structure refinement details are summarized in Table 2 ▸. A needle-like crystal elongated in the a direction was selected, picked up in the rayon loop and then quickly cryo-cooled in a stream of cold nitro­gen gas at the single-axis goniostat of the SER-CAT synchrotron station ID19 at the Advanced Photon Source, Argonne National Laboratory, USA. Diffraction images were collected with the use of MAR300 CCD detector in two passes differing in the effective exposure and resolution limits in order to adequately measure the weakest high-resolution reflections, as well as the strongest low-angle reflections without overloading detector pixels. All 38117 measured intensities from both passes were integrated, scaled and merged by HKL-2000 (Otwinowski & Minor, 1997 ▸) into the set of 4561 unique reflections with the overall R merge factor of 0.049. The data set is rather strong, with the I/σ(I) ratio equal to 25 at the highest resolution of 0.65 Å. H atoms were located in a difference synthesis and refined as riding on their parent atoms in geometrically idealized positions. Because of the short wavelength of synchrotron radiation, all Friedel mates were averaged during data processing. The chirality of the mol­ecule was deduced from the known chiral centres in the substrates used in chemical synthesis.
Table 2

Experimental details

Crystal data
Chemical formulaC20H37N3O4
M r 383.59
Crystal system, space groupMonoclinic, P21
Temperature (K)100
a, b, c ()10.85(1), 9.510(9), 11.200(11)
()94.85(2)
V (3)1152(2)
Z 2
Radiation typeSynchrotron, = 0.6199
(mm1)0.09
Crystal size (mm)0.30 0.05 0.02
 
Data collection
DiffractometerMAR300 CCD
Absorption correctionMulti-scan (SCALEPACK; Otwinowski et al., 2003)
T min, T max 0.974, 0.999
No. of measured, independent and observed [I > 2(I)] reflections4561, 4561, 4492
R int 0.049
(sin /)max (1)0.767
 
Refinement
R[F 2 > 2(F 2)], wR(F 2), S 0.041, 0.115, 1.07
No. of reflections4561
No. of parameters244
No. of restraints1
H-atom treatmentH-atom parameters constrained
max, min (e 3)0.44, 0.29

Computer programs: HKL-2000 (Otwinowski Minor, 1997 ▸), SHELXD and SHELXL97 (Sheldrick, 2008 ▸), ORTEP-3 for Windwows (Farrugia, 2012 ▸) and pyMOL (DeLano, 2002 ▸).

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989015002091/gk2625sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989015002091/gk2625Isup2.hkl CCDC reference: 1046561 Additional supporting information: crystallographic information; 3D view; checkCIF report
C20H37N3O4F(000) = 460
Mr = 383.59Dx = 1.110 Mg m3
Monoclinic, P21Synchrotron radiation, λ = 0.6199 Å
a = 10.85 (1) Åθ = 1.5–28.4°
b = 9.510 (9) ŵ = 0.09 mm1
c = 11.200 (11) ÅT = 100 K
β = 94.85 (2)°Needle, colourless
V = 1152 (2) Å30.30 × 0.05 × 0.02 mm
Z = 2
MAR300 CCD diffractometer4561 independent reflections
Radiation source: SER-CAT 22ID synchrotron beamline, APS, USA4492 reflections with I > 2σ(I)
Si111 double crystal monochromatorRint = 0.049
ω scansθmax = 28.4°, θmin = 1.5°
Absorption correction: multi-scan (SCALEPACK; Otwinowski et al., 2003)h = 0→16
Tmin = 0.974, Tmax = 0.999k = 0→14
4561 measured reflectionsl = −17→17
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.041Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.115H-atom parameters constrained
S = 1.07w = 1/[σ2(Fo2) + (0.081P)2 + 0.1533P] where P = (Fo2 + 2Fc2)/3
4561 reflections(Δ/σ)max < 0.001
244 parametersΔρmax = 0.44 e Å3
1 restraintΔρmin = −0.29 e Å3
Experimental. diffraction data were measured at the station 22ID of the APS synchrotron by rotation method a in three sweeps of different exposure and all data were scaled and merged into one data set
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against all reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on all data will be even larger.
xyzUiso*/Ueq
C100.26159 (10)0.47871 (12)0.27033 (9)0.01223 (18)
C110.14253 (11)0.53384 (15)0.20793 (12)0.0195 (2)
H1010.14860.63590.19810.029*
H1020.07370.51200.25620.029*
H1030.12800.48930.12910.029*
O120.27570 (9)0.35222 (10)0.29248 (11)0.02159 (19)
N200.34966 (8)0.57472 (10)0.29951 (8)0.01103 (15)
H2010.33360.66330.28180.013*
C210.48033 (9)0.60494 (11)0.48414 (8)0.00972 (16)
O210.46004 (9)0.73127 (9)0.49827 (7)0.01513 (16)
C220.47046 (9)0.54014 (11)0.35897 (8)0.00941 (16)
H2210.48040.43580.36480.011*
C230.57151 (10)0.60292 (12)0.28663 (10)0.01324 (18)
H2310.56860.55420.20830.016*
H2320.55150.70310.27050.016*
C240.70443 (11)0.59414 (15)0.34574 (12)0.0197 (2)
H2410.70630.63980.42630.024*
C250.79082 (15)0.6765 (2)0.2697 (2)0.0362 (4)
H2510.76060.77310.25890.054*
H2520.79270.63120.19130.054*
H2530.87440.67770.31030.054*
C260.75042 (14)0.44426 (18)0.36297 (19)0.0322 (3)
H2610.69470.39220.41140.048*
H2620.83390.44500.40400.048*
H2630.75240.39870.28470.048*
N300.51541 (8)0.51775 (10)0.57466 (8)0.01027 (15)
H3010.52370.42740.56060.012*
C310.65117 (9)0.49218 (11)0.75420 (9)0.01002 (17)
O310.64628 (8)0.36532 (9)0.77767 (8)0.01517 (16)
C320.53994 (9)0.57155 (11)0.69646 (8)0.00945 (16)
H3210.56070.67380.69280.011*
C330.42768 (10)0.55287 (12)0.76899 (9)0.01255 (18)
H3310.40340.45250.76650.015*
H3320.35780.60750.72990.015*
C340.44800 (10)0.59874 (13)0.90039 (9)0.01353 (18)
H3410.51670.54080.94000.016*
C350.48372 (15)0.75302 (16)0.91469 (12)0.0239 (3)
H3510.49560.77651.00010.036*
H3520.41780.81180.87590.036*
H3530.56080.77010.87730.036*
C360.33127 (12)0.56946 (18)0.96323 (11)0.0233 (3)
H3610.34420.59881.04720.035*
H3620.31280.46860.95940.035*
H3630.26180.62210.92350.035*
N400.75393 (9)0.56824 (11)0.77879 (9)0.01460 (17)
H4010.75560.65780.75930.018*
C410.83380 (14)0.45232 (19)0.96234 (14)0.0283 (3)
H4110.76270.48980.99490.034*
O410.89574 (15)0.3697 (2)1.02126 (16)0.0518 (5)
C420.86236 (11)0.50104 (14)0.83793 (12)0.0187 (2)
H4210.88490.41770.78980.022*
C430.97094 (12)0.60363 (17)0.84929 (13)0.0235 (2)
H4311.04160.55830.89600.028*
H4320.94710.68740.89450.028*
C441.01242 (12)0.65110 (17)0.72874 (14)0.0244 (3)
H4410.94260.69960.68330.029*
H4421.08050.72000.74320.029*
C451.05617 (19)0.5319 (2)0.65273 (18)0.0373 (4)
H4510.98550.46860.63070.045*
H4521.11960.47700.70130.045*
C461.1102 (2)0.5807 (3)0.53884 (19)0.0458 (5)
H4611.13630.49870.49430.069*
H4621.18180.64140.55970.069*
H4631.04740.63330.48910.069*
U11U22U33U12U13U23
C100.0124 (4)0.0105 (4)0.0138 (4)0.0002 (3)0.0009 (3)−0.0023 (3)
C110.0134 (4)0.0200 (6)0.0243 (5)0.0018 (4)−0.0028 (4)0.0005 (4)
O120.0181 (4)0.0080 (4)0.0378 (5)−0.0016 (3)−0.0023 (3)−0.0013 (4)
N200.0141 (3)0.0063 (3)0.0121 (3)0.0006 (3)−0.0030 (3)0.0008 (3)
C210.0143 (4)0.0062 (4)0.0083 (4)0.0003 (3)−0.0016 (3)−0.0008 (3)
O210.0277 (4)0.0051 (3)0.0119 (3)0.0031 (3)−0.0024 (3)−0.0008 (3)
C220.0135 (4)0.0060 (4)0.0082 (3)0.0008 (3)−0.0019 (3)−0.0008 (3)
C230.0150 (4)0.0110 (4)0.0139 (4)0.0012 (3)0.0020 (3)−0.0001 (3)
C240.0141 (4)0.0181 (5)0.0267 (5)0.0019 (4)0.0008 (4)−0.0001 (4)
C250.0208 (6)0.0296 (8)0.0591 (11)−0.0023 (6)0.0089 (6)0.0118 (8)
C260.0195 (5)0.0219 (7)0.0548 (10)0.0055 (5)0.0012 (6)0.0079 (7)
N300.0172 (4)0.0056 (3)0.0075 (3)0.0006 (3)−0.0020 (3)−0.0005 (3)
C310.0132 (4)0.0072 (4)0.0092 (3)0.0003 (3)−0.0015 (3)−0.0003 (3)
O310.0204 (4)0.0062 (3)0.0180 (3)−0.0007 (3)−0.0035 (3)0.0011 (3)
C320.0137 (4)0.0065 (4)0.0077 (3)0.0000 (3)−0.0015 (3)−0.0008 (3)
C330.0133 (4)0.0132 (4)0.0109 (4)−0.0011 (3)−0.0002 (3)−0.0013 (3)
C340.0167 (4)0.0143 (5)0.0096 (4)0.0008 (4)0.0013 (3)−0.0005 (3)
C350.0375 (7)0.0162 (6)0.0185 (5)−0.0037 (5)0.0052 (5)−0.0075 (4)
C360.0211 (5)0.0331 (7)0.0164 (5)0.0007 (5)0.0065 (4)0.0021 (5)
N400.0135 (4)0.0083 (4)0.0209 (4)−0.0013 (3)−0.0051 (3)0.0030 (3)
C410.0235 (6)0.0324 (8)0.0273 (6)−0.0049 (5)−0.0078 (5)0.0109 (6)
O410.0423 (7)0.0570 (11)0.0533 (9)0.0014 (7)−0.0120 (6)0.0360 (8)
C420.0142 (4)0.0163 (5)0.0242 (5)−0.0006 (4)−0.0061 (4)0.0056 (4)
C430.0170 (5)0.0249 (6)0.0276 (6)−0.0069 (5)−0.0039 (4)0.0006 (5)
C440.0181 (5)0.0226 (6)0.0323 (6)−0.0030 (5)0.0002 (4)0.0042 (5)
C450.0417 (9)0.0321 (9)0.0394 (8)−0.0022 (7)0.0114 (7)−0.0022 (7)
C460.0419 (9)0.0611 (15)0.0356 (8)−0.0080 (10)0.0094 (7)−0.0023 (9)
C10—O121.2351 (19)C33—C341.533 (2)
C10—N201.3420 (17)C33—H3310.9900
C10—C111.5097 (19)C33—H3320.9900
C11—H1010.9800C34—C351.522 (2)
C11—H1020.9800C34—C361.526 (2)
C11—H1030.9800C34—H3411.0000
N20—C221.4567 (17)C35—H3510.9800
N20—H2010.8800C35—H3520.9800
C21—O211.2340 (18)C35—H3530.9800
C21—N301.3398 (16)C36—H3610.9800
C21—C221.5268 (19)C36—H3620.9800
C22—C231.5380 (18)C36—H3630.9800
C22—H2211.0000N40—C421.4489 (17)
C23—C241.537 (2)N40—H4010.8800
C23—H2310.9900C41—O411.196 (2)
C23—H2320.9900C41—C421.525 (2)
C24—C261.517 (3)C41—H4110.9500
C24—C251.534 (2)C42—C431.527 (2)
C24—H2411.0000C42—H4211.0000
C25—H2510.9800C43—C441.527 (2)
C25—H2520.9800C43—H4310.9900
C25—H2530.9800C43—H4320.9900
C26—H2610.9800C44—C451.517 (3)
C26—H2620.9800C44—H4410.9900
C26—H2630.9800C44—H4420.9900
N30—C321.4602 (18)C45—C461.521 (3)
N30—H3010.8800C45—H4510.9900
C31—O311.2369 (18)C45—H4520.9900
C31—N401.3380 (16)C46—H4610.9800
C31—C321.5207 (17)C46—H4620.9800
C32—C331.5305 (18)C46—H4630.9800
C32—H3211.0000
O12—C10—N20122.69 (12)C34—C33—H331108.6
O12—C10—C11121.19 (11)C32—C33—H332108.6
N20—C10—C11116.12 (12)C34—C33—H332108.6
C10—C11—H101109.5H331—C33—H332107.5
C10—C11—H102109.5C35—C34—C36109.95 (11)
H101—C11—H102109.5C35—C34—C33112.95 (10)
C10—C11—H103109.5C36—C34—C33109.47 (10)
H101—C11—H103109.5C35—C34—H341108.1
H102—C11—H103109.5C36—C34—H341108.1
C10—N20—C22123.53 (11)C33—C34—H341108.1
C10—N20—H201118.2C34—C35—H351109.5
C22—N20—H201118.2C34—C35—H352109.5
O21—C21—N30123.22 (11)H351—C35—H352109.5
O21—C21—C22120.75 (9)C34—C35—H353109.5
N30—C21—C22116.00 (11)H351—C35—H353109.5
N20—C22—C21108.61 (9)H352—C35—H353109.5
N20—C22—C23108.99 (10)C34—C36—H361109.5
C21—C22—C23109.22 (10)C34—C36—H362109.5
N20—C22—H221110.0H361—C36—H362109.5
C21—C22—H221110.0C34—C36—H363109.5
C23—C22—H221110.0H361—C36—H363109.5
C24—C23—C22115.88 (11)H362—C36—H363109.5
C24—C23—H231108.3C31—N40—C42119.07 (12)
C22—C23—H231108.3C31—N40—H401120.5
C24—C23—H232108.3C42—N40—H401120.5
C22—C23—H232108.3O41—C41—C42123.77 (18)
H231—C23—H232107.4O41—C41—H411118.1
C26—C24—C25109.90 (13)C42—C41—H411118.1
C26—C24—C23113.10 (11)N40—C42—C41109.39 (12)
C25—C24—C23109.16 (13)N40—C42—C43110.32 (13)
C26—C24—H241108.2C41—C42—C43109.45 (11)
C25—C24—H241108.2N40—C42—H421109.2
C23—C24—H241108.2C41—C42—H421109.2
C24—C25—H251109.5C43—C42—H421109.2
C24—C25—H252109.5C42—C43—C44113.48 (12)
H251—C25—H252109.5C42—C43—H431108.9
C24—C25—H253109.5C44—C43—H431108.9
H251—C25—H253109.5C42—C43—H432108.9
H252—C25—H253109.5C44—C43—H432108.9
C24—C26—H261109.5H431—C43—H432107.7
C24—C26—H262109.5C45—C44—C43113.88 (15)
H261—C26—H262109.5C45—C44—H441108.8
C24—C26—H263109.5C43—C44—H441108.8
H261—C26—H263109.5C45—C44—H442108.8
H262—C26—H263109.5C43—C44—H442108.8
C21—N30—C32120.51 (11)H441—C44—H442107.7
C21—N30—H301119.7C44—C45—C46113.8 (2)
C32—N30—H301119.7C44—C45—H451108.8
O31—C31—N40122.24 (11)C46—C45—H451108.8
O31—C31—C32121.86 (10)C44—C45—H452108.8
N40—C31—C32115.90 (11)C46—C45—H452108.8
N30—C32—C31107.38 (9)H451—C45—H452107.7
N30—C32—C33111.39 (9)C45—C46—H461109.5
C31—C32—C33110.81 (10)C45—C46—H462109.5
N30—C32—H321109.1H461—C46—H462109.5
C31—C32—H321109.1C45—C46—H463109.5
C33—C32—H321109.1H461—C46—H463109.5
C32—C33—C34114.85 (10)H462—C46—H463109.5
C32—C33—H331108.6
O12—C10—N20—C220.51 (17)N40—C31—C32—N30112.91 (11)
C11—C10—N20—C22−179.42 (9)O31—C31—C32—C3354.24 (13)
C10—N20—C22—C21−113.52 (11)N40—C31—C32—C33−125.23 (10)
C10—N20—C22—C23127.58 (11)N30—C32—C33—C34176.58 (9)
O21—C21—C22—N20−53.20 (13)C31—C32—C33—C3457.10 (13)
N30—C21—C22—N20128.72 (9)C32—C33—C34—C3559.28 (13)
O21—C21—C22—C2365.55 (14)C32—C33—C34—C36−177.85 (10)
N30—C21—C22—C23−112.52 (11)O31—C31—N40—C42−1.75 (17)
N20—C22—C23—C24171.82 (10)C32—C31—N40—C42177.72 (10)
C21—C22—C23—C2453.30 (13)C31—N40—C42—C41−63.52 (15)
C22—C23—C24—C2664.09 (15)C31—N40—C42—C43176.03 (11)
C22—C23—C24—C25−173.23 (12)O41—C41—C42—N40164.16 (18)
O21—C21—N30—C32−4.26 (16)O41—C41—C42—C43−74.9 (2)
C22—C21—N30—C32173.77 (9)N40—C42—C43—C44−63.46 (16)
C21—N30—C32—C31−141.31 (10)C41—C42—C43—C44176.13 (13)
C21—N30—C32—C3397.19 (12)C42—C43—C44—C45−60.78 (18)
O31—C31—C32—N30−67.62 (13)C43—C44—C45—C46−173.82 (15)
D—H···AD—HH···AD···AD—H···A
N20—H201···O31i0.882.052.897 (3)161
N30—H301···O21ii0.881.992.863 (3)171
N40—H401···O12i0.881.962.827 (3)169
  20 in total

1.  Multiparametric scaling of diffraction intensities.

Authors:  Zbyszek Otwinowski; Dominika Borek; Wladyslaw Majewski; Wladek Minor
Journal:  Acta Crystallogr A       Date:  2003-04-25       Impact factor: 2.290

Review 2.  Proteasome inhibitors: recent advances and new perspectives in medicinal chemistry.

Authors:  E Genin; M Reboud-Ravaux; J Vidal
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

Review 3.  20S proteasome and its inhibitors: crystallographic knowledge for drug development.

Authors:  Ljudmila Borissenko; Michael Groll
Journal:  Chem Rev       Date:  2007-02-23       Impact factor: 60.622

Review 4.  Development of proteasome inhibitors in oncology and autoimmune diseases.

Authors:  Mark K Bennett; Christopher J Kirk
Journal:  Curr Opin Drug Discov Devel       Date:  2008-09

Review 5.  The proteasome in health and disease.

Authors:  Elzbieta Jankowska; Julia Stoj; Przemyslaw Karpowicz; Pawel A Osmulski; Maria Gaczynska
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

6.  Cyclodextrins as templates for the presentation of protease inhibitors.

Authors:  N Schaschke; H J Musiol; I Assfalg-Machleidt; W Machleidt; S Rudolph-Böhner; L Moroder
Journal:  FEBS Lett       Date:  1996-08-12       Impact factor: 4.124

Review 7.  Proteasome structure, function, and lessons learned from beta-lactone inhibitors.

Authors:  Michael Groll; Barbara C Potts
Journal:  Curr Top Med Chem       Date:  2011-12       Impact factor: 3.295

8.  Covalent complexes of proteasome model with peptide aldehyde inhibitors MG132 and MG101: docking and molecular dynamics study.

Authors:  Siwei Zhang; Yawei Shi; Hongwei Jin; Zhenming Liu; Liangren Zhang; Lihe Zhang
Journal:  J Mol Model       Date:  2009-05-14       Impact factor: 1.810

Review 9.  Dysfunction of the ubiquitin-proteasome system in multiple disease conditions: therapeutic approaches.

Authors:  Subhankar Paul
Journal:  Bioessays       Date:  2008-11       Impact factor: 4.345

Review 10.  Role of proteasomes in disease.

Authors:  Burkhardt Dahlmann
Journal:  BMC Biochem       Date:  2007-11-22       Impact factor: 4.059

View more
  1 in total

1.  The Toxic Effect of ALLN on Primary Rat Retinal Neurons.

Authors:  Na Li; Lei Shang; Shu-Chao Wang; Lv-Shuang Liao; Dan Chen; Ju-Fang Huang; Kun Xiong
Journal:  Neurotox Res       Date:  2016-05-19       Impact factor: 3.911

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.